This study aimed to investigate the role of
fatty acid synthase (FASN) in the epithelial-mesenchymal transition (EMT) of
breast cancer cells. MCF-7 cells and MCF-7 cells overexpressing
mitogen-activated protein kinase 5 (MCF-7-MEK5) were used in this study. MCF-7-MEK5 cells showed stable EMT characterized by increased
vimentin and decreased
E-cadherin expression. An In vivo animal model was established using the orthotopic injection of MCF-7 or MCF-7-MEK5 cells. Real-time quantitative PCR and western blotting were used to detect the expression levels of FASN and its downstream
proteins liver fatty acid-binding protein (L-FABP) and
VEGF/VEGFR-2 in both in vitro and in vivo models (nude mouse
tumor tissues). In MCF-7-MEK5 cells, significantly increased expression of FASN was associated with increased levels of L-FABP and
VEGF/VEGFR-2.
Cerulenin inhibited MCF-7-MEK5 cell migration and EMT, and reduced FASN expression and down-stream
proteins L-FABP,
VEGF, and
VEGFR-2. MCF-7-MEK5 cells showed higher sensitivity to
Cerulenin than MCF-7 cells. Immunofluorescence revealed an increase of co-localization of FASN with
VEGF on the cell membrane and with L-FABP within MCF-7-MEK5 cells. Immunohistochemistry further showed that increased percentage of FASN-positive cells in the
tumor tissue was associated with increased percentages of L-FABP- and
VEGF-positive cells and the
Cerulenin treatment could reverse the effect. Altogether, our results suggest that FASN is essential to EMT possibly through regulating L-FABP,
VEGF and
VEGFR-2. This study provides a theoretical basis and potential strategy for effective suppression of malignant cells with EMT.